Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VVT MedVVTMF EV-to-EBIT is -3.52 as of Jul. 29, 2026. The stock has 5 warning signs investors should review. Among 468 Medical Devices & Instruments companies, VVT Med ranks worse than 213675% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, VVT Med's Enterprise Value is $12.92 Mil.
VVT Med's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $-3.67 Mil. Therefore, VVT Med's EV-to-EBIT for today is -3.52.
The historical rank and industry rank for VVT Med's EV-to-EBIT or its related term are showing as below:
VVTMF'
s EV-to-EBIT Range Over the Past 10 Years
Min: -31.85 Med: -4.1 Max: -2.66
Current: -3.6
During the past 4 years, the highest EV-to-EBIT of VVT Med was -2.66. The lowest was -31.85. And the median was -4.10.
VVTMF's EV-to-EBIT is ranked worse than 100% of 468
companies
in the Medical Devices & Instruments industry
Industry Median: 18.695
vs VVTMF: -3.60
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
VVT Med's Enterprise Value for the quarter that ended in Mar. 2026 was $3.70 Mil.
VVT Med's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.67 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VVT Med EV-to-EBIT Related Terms
VVT Med EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for VVT Med's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, VVT Med's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
VVT Med EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, VVT Med's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where VVT Med's EV-to-EBIT falls into.
VVT Med's current Enterprise Value is $12.92 Mil.
VVT Med's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.67 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VVT Med (VVTMF) has a EV-to-EBIT of -3.52 as of Jul. 29, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on VVT Med and its competitors. According to the industry distribution chart, VVT Med ranks #999999 out of 468 companies in the Medical Devices & Instruments industry.
Is VVT Med's EV-to-EBIT too high?
VVT Med's current EV-to-EBIT is -3.52. Based on the distribution chart, VVT Med ranks #999999 out of 468 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does VVT Med's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, VVT Med ranks #999999 out of 468 companies for EV-to-EBIT. This places VVT Med in the lower half of its industry. The industry median EV-to-EBIT is 18.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.70, based on 468 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on VVT Med and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. VVT Med's current EV-to-EBIT is -3.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VVT Med stock overvalued right now?
VVT Med (VVTMF) has a current EV-to-EBIT of -3.52. The current EV-to-EBIT is -3.52. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For VVT Med (VVTMF), the current EV-to-EBIT is -3.52 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
VVT Med Inc is a medical device company, focused on developing and commercializing a range of minimally invasive technologies for treating varicose veins. VVT's research and development activities are based in Israel. The company proudly boasts three products within its portfolio that have achieved commercial production status and are currently available in the market. These products have undergone meticulous design processes, obtaining regulatory approvals across multiple countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VVTMF has been successfully added to your 
